Skip to main content

Table 2 P63 expression of in current series and in other published series

From: Can p63 serve as a biomarker for giant cell tumor of bone? A Moroccan experience

Diagnosis Our series Dickson’s series [[4]] De la Rosa’s series [[3]] Lee’s series [[6]]
  N° of cases P63+ cases (%) N° of cases P63+ cases (%) N° of cases P63+ cases (%) N° of cases P63+ cases (%)
GCTOB 5 100% 17 100% 23 86.9% 6 81%
Osteosarcoma 12 8.3% 0 - 4 50% 13 15.3%
Osteoblastoma 8 37.5% 0 - 0 - 0 -
ABC 5 40% 7 28.6% 8 62.5% 25 20%
CGCG 4 0% 12 0% 4 100% 12 0%
NOF 4 25% 0 - 6 16.6% 0 -
OO 4 50% 0 - 0 - 0 -
CMF 3 33.4% 0 - 0 - 12 0%
Chondroblastoma 1 100% 10 30% 12 83.3% 15 40%
FD 1 0% 0 - 2 0% 4 0%
LCH 1 0% 0 - 0 - 0 -
chondrosarcoma 0 - 0 - 0 - 0 -
Brown tumor 0 - 0 - 0 - 4 0%